Masaki Otagiri Selected Research

Drug Overdose

10/2005	A molecular functional study on the interactions of drugs with plasma proteins.
1/2005	How tightly can a drug be bound to a protein and still be removable by charcoal hemoperfusion in overdose cases?
6/2002	Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masaki Otagiri Research Topics

Disease

27	Neoplasms (Cancer) 01/2024 - 05/2002
17	Chronic Renal Insufficiency 01/2024 - 04/2011
16	Inflammation (Inflammations) 01/2024 - 06/2007
11	Chronic Kidney Failure (Chronic Renal Failure) 11/2021 - 05/2002
10	Hemorrhage 01/2021 - 04/2011
9	Fibrosis (Cirrhosis) 02/2024 - 12/2008
8	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 03/2014
8	Renal Insufficiency (Renal Failure) 12/2023 - 08/2004
8	Hemorrhagic Shock 11/2020 - 06/2009
6	Ischemia 01/2024 - 03/2007
6	Reperfusion Injury 01/2024 - 07/2010
6	Hypoxia (Hypoxemia) 01/2022 - 02/2015
6	Infections 01/2021 - 01/2013
6	Uremia 09/2009 - 05/2002
5	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 11/2010
5	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 09/2017
5	Lung Injury 11/2020 - 09/2011
5	Wounds and Injuries (Trauma) 01/2020 - 02/2015
5	Anemia 01/2018 - 08/2004
4	Inborn Urea Cycle Disorders 01/2024 - 01/2017
4	Hepatitis 12/2023 - 04/2014
4	Secondary Hyperparathyroidism 01/2020 - 04/2011
3	Sarcopenia 04/2024 - 01/2016
3	Rhabdomyolysis 01/2024 - 09/2015
3	Body Weight (Weight, Body) 06/2023 - 01/2010
3	Poisoning 01/2022 - 10/2021
3	Alcoholic Fatty Liver 03/2021 - 01/2020
3	Hypertension (High Blood Pressure) 02/2019 - 12/2009
3	Atrophy 10/2017 - 02/2002
3	Thrombocytopenia (Thrombopenia) 11/2015 - 10/2013
3	Hypoalbuminemia 02/2015 - 05/2006
3	Polyneuropathies (Polyneuropathy) 12/2013 - 08/2005
3	Sepsis (Septicemia) 01/2013 - 04/2011
3	Drug Overdose 10/2005 - 06/2002
2	Muscular Atrophy (Muscle Atrophy) 04/2024 - 01/2016
2	Chronic Hepatitis (Chronic Active Hepatitis) 02/2024 - 01/2020
2	Necrosis 01/2024 - 10/2022

Drug/Important Bio-Agent (IBA)

28	AlbuminsIBA 02/2024 - 05/2002
19	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2005
19	Human Serum Albumin FDA LinkGeneric 12/2023 - 12/2008
14	Carbon MonoxideIBA 04/2024 - 01/2013
14	Therapeutic UsesIBA 01/2024 - 05/2013
14	human S-nitrosoalbuminIBA 01/2020 - 12/2008
12	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 07/2007
12	Hemoglobins (Hemoglobin)IBA 12/2021 - 06/2009
11	AntioxidantsIBA 12/2023 - 04/2011
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2022 - 08/2005
9	Liposomes (Liposome)IBA 12/2021 - 03/2011
9	Uremic ToxinsIBA 01/2016 - 05/2002
8	CytokinesIBA 02/2024 - 09/2011
7	IndicanIBA 10/2017 - 05/2002
6	ThioredoxinsIBA 11/2020 - 09/2011
5	Serum AlbuminIBA 01/2024 - 08/2008
5	4-phenylbutyric acid (Buphenyl)FDA Link 01/2024 - 01/2017
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 04/2005
5	ChitosanIBA 02/2021 - 06/2012
5	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2020 - 01/2013
5	Oxygen (Dioxygen)IBA 01/2016 - 06/2009
4	Blood Proteins (Serum Proteins)IBA 12/2023 - 04/2009
4	Antineoplastic Agents (Antineoplastics)IBA 08/2021 - 07/2014
4	Sulfates (Sulfates, Inorganic)IBA 02/2015 - 01/2010
4	Glycoproteins (Glycoprotein)IBA 08/2013 - 07/2007
4	Advanced Glycation End ProductsIBA 04/2011 - 04/2007
3	Messenger RNA (mRNA)IBA 04/2024 - 04/2013
3	MyostatinIBA 04/2024 - 01/2016
3	Carbon Tetrachloride (Tetrachloromethane)IBA 02/2024 - 11/2010
3	Hydroxyproline (4 Hydroxyproline)IBA 02/2024 - 05/2013
3	CreatinineIBA 01/2024 - 01/2010
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2023 - 12/2007
3	Oleic Acid (Oleate)IBA 12/2023 - 12/2008
3	Concanavalin AIBA 12/2023 - 11/2018
3	Cisplatin (Platino)FDA LinkGeneric 09/2023 - 03/2014
3	Cyanides (Isocyanides)IBA 01/2022 - 10/2021
3	MethemoglobinIBA 01/2022 - 10/2021
3	AntidotesIBA 01/2022 - 10/2021
3	SuspensionsIBA 12/2021 - 01/2013
3	NucleosidesIBA 05/2021 - 06/2018
3	4'-cyano-2'-deoxyguanosineIBA 05/2021 - 06/2018
3	BenzbromaroneIBA 01/2021 - 01/2015
3	ChitinIBA 12/2020 - 09/2016
3	Ether (Diethyl Ether)IBA 02/2019 - 09/2016
3	CyclodextrinsIBA 02/2019 - 09/2016
3	Adenosine Diphosphate (ADP)IBA 09/2015 - 08/2013
3	Fibrinogen (Factor I)FDA Link 09/2015 - 08/2013
3	Immunoglobulin M (IgM)IBA 09/2015 - 03/2011
3	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2015 - 12/2012
3	Hydroxyl RadicalIBA 01/2015 - 10/2008
3	Prealbumin (Transthyretin)IBA 12/2013 - 08/2005
3	Amyloid (Amyloid Fibrils)IBA 12/2013 - 08/2005
3	hippuric acidIBA 02/2006 - 04/2005
2	Interferon Type IIBA 02/2024 - 11/2018
2	Indicators and Reagents (Reagents)IBA 01/2024 - 08/2005
2	Dextrans (Dextran)FDA Link 11/2022 - 07/2007

Therapy/Procedure

20	Therapeutics 02/2024 - 08/2007
16	Renal Dialysis (Hemodialysis) 01/2024 - 08/2004
9	Resuscitation 11/2020 - 06/2009
3	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2024 - 01/2020
3	Drug Therapy (Chemotherapy) 10/2022 - 01/2013
2	Intravenous Administration 01/2024 - 05/2013
2	Oral Administration 06/2023 - 01/2018